The official blog of the Lung Institute.

Lung Institute Doctors Attend Mayo Clinic Seminar

15 May 2015
| Under Press | Posted by
Mayo Clinic Pulmonary Fibrosis Seminar

2015 Multidisciplinary Update in Pulmonary and Critical Care Medicine

Tampa, FL (May 15, 2015) – The 2015 Multidisciplinary Update in Pulmonary and Critical Care Medicine proved to be a successful and informative event, held at the end of April in Scottsdale, AZ. The seminar included lectures, case studies, literature reviews and state-of-the-art updates regarding pulmonary health. It is intended for healthcare professionals in Pulmonology, Critical Care, Internal Medicine, Hospital Medicine, Thoracic Surgeons and other related fields. The event centers on comprehensive care for pulmonary disorders. A Lung Institute doctor attended the conference to stay informed on cutting edge technology in the field of pulmonary study.

While the Lung Institute specializes in cellular therapy to treat those suffering from debilitating lung disease, the Lung Institute recognizes that it is imperative to stay up to date with the medical advancements in the industry in order to offer the most effective care to their patients. Lectures at the event were given by leaders in pulmonary and critical care medicine, pulmonary pathology and radiology. The comprehensive approach to pulmonary care provides event-goers with well rounded, cutting edge information in the field.

Some hot topics at the seminar included: acute respiratory distress syndrome (ARDS), new pulmonary hypertension treatment breakthroughs, updates in sepsis management, noninvasive ventilation strategies, current state of lung transplant research and more.

About the Lung Institute

At the Lung Institute, we are changing people’s lives across the nation through the innovative technology of regenerative medicine. We recognize the challenges of finding effective and sustainable treatment options for patients who might be suffering from debilitating lung diseases, and we are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our goal is to help patients breathe easier and bring life back within reach. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.